ACCD stock icon

Accolade

3.58 USD
-0.17
4.53%
At close Oct 17, 4:00 PM EDT
After hours
3.62
+0.04
1.12%
1 day
-4.53%
5 days
-5.29%
1 month
-16.94%
3 months
-6.77%
6 months
-58.85%
Year to date
-70.44%
1 year
-50.42%
5 years
-87.95%
 

About: Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Employees: 2,400

0
Funds holding %
of 6,740 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

62% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 37

1% less funds holding

Funds holding: 149 [Q1] → 148 (-1) [Q2]

4% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 28

7.01% less ownership

Funds ownership: 89.28% [Q1] → 82.27% (-7.01%) [Q2]

50% less funds holding in top 10

Funds holding in top 10: 4 [Q1] → 2 (-2) [Q2]

67% less capital invested

Capital invested by funds: $724M [Q1] → $236M (-$489M) [Q2]

88% less call options, than puts

Call options by funds: $792K | Put options by funds: $6.78M

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$5
40%
upside
Avg. target
$7.07
98%
upside
High target
$8
123%
upside

7 analyst ratings

positive
71%
neutral
29%
negative
0%
Wells Fargo
Stan Berenshteyn
71% 1-year accuracy
5 / 7 met price target
68%upside
$6
Equal-Weight
Maintained
11 Oct 2024
Truist Securities
Jailendra Singh
34% 1-year accuracy
12 / 35 met price target
110%upside
$7.50
Buy
Maintained
9 Oct 2024
Canaccord Genuity
Richard Close
41% 1-year accuracy
9 / 22 met price target
96%upside
$7
Buy
Maintained
9 Oct 2024
Barclays
Stephanie Davis
78% 1-year accuracy
7 / 9 met price target
40%upside
$5
Equal-Weight
Maintained
9 Oct 2024
Stephens & Co.
Jeff Garro
50% 1-year accuracy
2 / 4 met price target
123%upside
$8
Overweight
Maintained
9 Oct 2024

Financial journalist opinion

Based on 9 articles about ACCD published over the past 30 days

Charts implemented using Lightweight Charts™